FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Seattle, United States

Biotech startups in Seattle, United States

Updated 16 Nov 2026

Reset
Biotech startups in Seattle, United States
One-time CSV
  • 86 funded companies, 67 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~seattle-washington.csv86 rows × 18 columns
CompanyCityLast roundAmountDate
Avalyn PharmaSeattleSeries D$100.0M2025-07-22
InduProSeattleSeries B$77.0M2026-08-12
Talus BioSeattleSeed$11.2M2026-09-21
Parse BiosciencesSeattleSeries C$50.0M2023-12-14
Umoja BiopharmaSeattleSeries C$100.0M2025-01-14
Curi BioSeattleSeries B$10.0M2025-12-02
ZipBioSeattleSeed$4.0M2024-09-05
ProfoundBioSeattleSeries B$112.0M2024-02-13

8 rows of the CSV in 5 of its 18 columns.

86
Startups
$4.5B
Total raised
10
Funded in the last 12 months
$278.4M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

9 of 86
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Series B $77.0M 2026-08-12 $162.0M Euclidean Capital, The Column Group, Vida Ventures +1 51 to 100 2022
Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015
Lumen Bioscience Lumen Bioscience discovers, develops, and manufactures biologic drugs and vaccine candidates. Biotech Series C $30.0M 2025-10-08 $97.0M US Department of Energy, WestRiver Group 101 to 250 2017
Avalyn Pharma Avalyn Pharma develops therapies for idiopathic pulmonary fibrosis and other respiratory diseases. Biotech Series D $100.0M 2025-07-22 $372.5M Eight Roads Ventures, F-Prime, Wellington Management +2 11 to 50 2011
Umoja Biopharma Umoja Biopharma develops immunotherapies intended to treat cancer by engineering the body's own immune cells. Biotech Series C $100.0M 2025-01-14 $363.0M SoftBank Vision Fund, Temasek, Cormorant Asset Management +2 101 to 250 2019
ZipBio ZipBio develops gene therapies using machine learning, protein engineering, and molecular materials. Biotech Seed $4.0M 2024-09-05 $4.0M NFX, MoreVC 1 to 10 2022
Parse Biosciences Parse Biosciences develops single-cell sequencing kits for researchers. Biotech Series C $50.0M 2023-12-14 $100.0M National Science Foundation, Marshall Wace, Horizon Technology Finance +2 101 to 250 2018
Genemod Genemod provides a unified platform for life scientists to collaborate and manage lab operations. Biotech Seed $4.5M 2023-05-01 $8.2M Unpopular Ventures, Canaan Partners, Amino Capital +2 11 to 50 2018

Table 1. Biotech startups in Seattle, United States: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 86.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 InduPro InduPro develops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease. Biotech Series B $77.0M 2026-08-12 $162.0M Euclidean Capital, The Column Group, Vida Ventures +1 51 to 100 2022
2 Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
3 Curi Bio Curi Bio combines human stem cells, biological systems, and AI-enabled data analytics to develop new therapeutics. Artificial intelligence Series B $10.0M 2025-12-02 $30.4M National Institutes of Health, Dynamk Capital 11 to 50 2015

Table 2. Biotech startups in Seattle, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 3%
2 Madrona Venture capital firm Seattle, United States 3 3%
3 National Institutes of Health Entrepreneurship program Bethesda, United States 2 2% 2 Talus Bio, Curi Bio
4 National Science Foundation Entrepreneurship program Alexandria, United States 2 2% 1 Talus Bio
5 RA Capital Management Startup incubator Boston, United States 2 2%
6 OrbiMed Private equity firm New York, United States 2 2%
7 ARCH Venture Partners Venture capital firm Chicago, United States 2 2%
8 Wellington Management Private equity firm Boston, United States 1 1%
9 Eight Roads Ventures Venture capital firm London, United Kingdom 1 1%
10 F-Prime Venture capital firm Cambridge, United States 1 1%
11 Perceptive Advisors Hedge fund New York, United States 1 1%
12 Andera Partners Private equity firm Paris, France 1 1%
13 Euclidean Capital Family office New York, United States 1 1% 1 InduPro
14 MRL Ventures Fund Corporate venture arm Cambridge, United States 1 1% 1 InduPro
15 Vida Ventures Venture capital firm Boston, United States 1 1% 1 InduPro

Table 3. Biotech startups in Seattle, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 69 80% $4.0B
Software 15 17% $180.0M
Artificial intelligence 10 12% $98.9M
Hardware 3 3% $26.0M
Commerce 1 1% $4.4M

Table 4. Biotech startups in Seattle, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 8 9% $720K
Seed 26 30% $2.5M
Series A 19 22% $12.3M
Series B 23 27% $20.0M
Series C 8 9% $50.0M
Series D+ 2 2% $100.0M

Table 5. Biotech startups in Seattle, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 10% $4.2M
September 2026 5 50% $128.9M
August 2026 1 10% $77.0M
June 2026 1 10% $46.0M
December 2025 2 20% $22.3M

Table 6. Biotech startups in Seattle, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 8 9% $256.1M
2025 11 13% $472.0M
2024 7 8% $285.6M
2023 10 12% $153.3M
2022 9 10% $199.5M
2021 9 10% $278.7M

Table 7. Biotech startups in Seattle, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 7 8%
2020 to 2022 18 21%
2015 to 2019 28 33%
2010 to 2014 17 20%
Before 2010 14 17%

Table 8. Biotech startups in Seattle, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 37 44%
11 to 50 33 39%
51 to 100 7 8%
101 to 250 5 6%
251 to 500 1 1%
501 to 1,000 1 1%

Table 9. Biotech startups in Seattle, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Seattle, United States are on the list?
86, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 86 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Seattle, United States: 86 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Seattle, United States by funding stage

Other sectors in Seattle

Biotech startups elsewhere

Cite: FundingWatcher, 86 funded biotech companies in Seattle, United States, 16 November 2026. https://fundingwatcher.com/startups/biotech/seattle-washington/